Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 373 to 375 of 375 entries
Sorted by: Best Match Show Resources per page
Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema.

Thorax

Aaltonen HL, Petersson Sjögren M, Jakobsson JKF, Nicklasson H, Diaz S, Sánchez Montiel F, Zackrisson S, Ideböhn V, Engström G, Löndahl J, Wollmer P.
PMID: 33859054
Thorax. 2021 Oct;76(10):1040-1043. doi: 10.1136/thoraxjnl-2020-214523. Epub 2021 Apr 15.

Airspace dimension assessment with nanoparticles (AiDA) is a novel method to measure distal airspace radius non-invasively. In this study, AiDA radii were measured in 618 individuals from the population-based Swedish CArdiopulmonary BioImaging Study, SCAPIS. Subjects with emphysema detected by...

Cite
Aaltonen HL, Petersson Sjögren M, Jakobsson JKF, et al. Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema. Thorax. 2021;76(10):1040-1043doi: 10.1136/thoraxjnl-2020-214523.
Aaltonen, H. L., Petersson Sjögren, M., Jakobsson, J. K. F., Nicklasson, H., Diaz, S., Sánchez Montiel, F., Zackrisson, S., Ideböhn, V., Engström, G., Löndahl, J., & Wollmer, P. (2021). Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema. Thorax, 76(10), 1040-1043. https://doi.org/10.1136/thoraxjnl-2020-214523
Aaltonen, H Laura, et al. "Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema." Thorax vol. 76,10 (2021): 1040-1043. doi: https://doi.org/10.1136/thoraxjnl-2020-214523
Aaltonen HL, Petersson Sjögren M, Jakobsson JKF, Nicklasson H, Diaz S, Sánchez Montiel F, Zackrisson S, Ideböhn V, Engström G, Löndahl J, Wollmer P. Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema. Thorax. 2021 Oct;76(10):1040-1043. doi: 10.1136/thoraxjnl-2020-214523. Epub 2021 Apr 15. PMID: 33859054; PMCID: PMC8461447.
Copy Download .nbib Format: NLM
Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity.

Respiratory medicine

Kraen M, Frantz S, Nihlén U, Engström G, Löfdahl CG, Wollmer P, Dencker M.
PMID: 33895626
Respir Med. 2021 Jun;182:106404. doi: 10.1016/j.rmed.2021.106404. Epub 2021 Apr 17.

Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that in recent years has been reported to have significant effects on numerous tissues. Chronic obstructive pulmonary disease (COPD) is associated with hypophosphatemia but the evidence for elevated plasma levels...

Cite
Kraen M, Frantz S, Nihlén U, et al. Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity. Respir Med. 2021;182:106404doi: 10.1016/j.rmed.2021.106404.
Kraen, M., Frantz, S., Nihlén, U., Engström, G., Löfdahl, C. G., Wollmer, P., & Dencker, M. (2021). Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity. Respiratory medicine, 182106404. https://doi.org/10.1016/j.rmed.2021.106404
Kraen, M, et al. "Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity." Respiratory medicine vol. 182 (2021): 106404. doi: https://doi.org/10.1016/j.rmed.2021.106404
Kraen M, Frantz S, Nihlén U, Engström G, Löfdahl CG, Wollmer P, Dencker M. Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity. Respir Med. 2021 Jun;182:106404. doi: 10.1016/j.rmed.2021.106404. Epub 2021 Apr 17. PMID: 33895626.
Copy Download .nbib Format: NLM
Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study.

European journal of preventive cardiology

Östgren CJ, Söderberg S, Festin K, Angerås O, Bergström G, Blomberg A, Brandberg J, Cederlund K, Eliasson M, Engström G, Erlinge D, Fagman E, Hagström E, Lind L, Mannila M, Nilsson U, Oldgren J, Ostenfeld E, Persson A, Persson J, Persson M, Rosengren A, Sundström J, Swahn E, Engvall JE, Jernberg T.
PMID: 32126830
Eur J Prev Cardiol. 2020 Mar 03;2047487320909300. doi: 10.1177/2047487320909300. Epub 2020 Mar 03.

BACKGROUND: It is not clear if the European Systematic Coronary Risk Evaluation algorithm is useful for identifying prevalent subclinical atherosclerosis in a population of apparently healthy individuals. Our aim was to explore the association between the risk estimates from...

Cite
Östgren CJ, Söderberg S, Festin K, et al. Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study. Eur J Prev Cardiol. 2020;2047487320909300doi: 10.1177/2047487320909300.
Östgren, C. J., Söderberg, S., Festin, K., Angerås, O., Bergström, G., Blomberg, A., Brandberg, J., Cederlund, K., Eliasson, M., Engström, G., Erlinge, D., Fagman, E., Hagström, E., Lind, L., Mannila, M., Nilsson, U., Oldgren, J., Ostenfeld, E., Persson, A., Persson, J., Persson, M., Rosengren, A., Sundström, J., Swahn, E., Engvall, J. E., & Jernberg, T. (2020). Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study. European journal of preventive cardiology, 2047487320909300. https://doi.org/10.1177/2047487320909300
Östgren, Carl J, et al. "Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study." European journal of preventive cardiology vol. (2020): 2047487320909300. doi: https://doi.org/10.1177/2047487320909300
Östgren CJ, Söderberg S, Festin K, Angerås O, Bergström G, Blomberg A, Brandberg J, Cederlund K, Eliasson M, Engström G, Erlinge D, Fagman E, Hagström E, Lind L, Mannila M, Nilsson U, Oldgren J, Ostenfeld E, Persson A, Persson J, Persson M, Rosengren A, Sundström J, Swahn E, Engvall JE, Jernberg T. Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study. Eur J Prev Cardiol. 2020 Mar 03;2047487320909300. doi: 10.1177/2047487320909300. Epub 2020 Mar 03. PMID: 32126830.
Copy Download .nbib Format: NLM
Showing 373 to 375 of 375 entries